Given the fact that the prevalence and costs of dementia are expected to rise in conjunction with America’s changing demographics, there is an urgent need for health care providers and policy makers to prevent the fundamental causes of brain disease.
	It is within this context that many health care providers will need to revise their approach to medicating patients.
	Even though the construct is seldom mentioned by physicians in their clinical work, it is nevertheless significant that the American Psychiatric Association’s own diagnostic handbook (the DSM) has long recognized the fact that drugs of any kind may induce or enhance long-lasting, cognitive limitations.
	To the extent that psychopharmaceuticals contribute to brain dysfunction and dementia (i.e., substance-induced persisting dementia), they are perpetrators of a perfect crime.